Capricor Therapeutics Inc
NASDAQ:CAPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
S
|
Suryoday Small Finance Bank Ltd
NSE:SURYODAY
|
IN |
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
M
|
Minda Global Bhd
KLSE:MINDA
|
MY |
|
Staffing 360 Solutions Inc
NASDAQ:STAF
|
US |
|
Bergbahnen Engelberg Truebsee Titlis Bet AG
SIX:TIBN
|
CH |
Balance Sheet
Balance Sheet Decomposition
Capricor Therapeutics Inc
Capricor Therapeutics Inc
Balance Sheet
Capricor Therapeutics Inc
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
16
|
6
|
3
|
3
|
1
|
0
|
2
|
8
|
6
|
3
|
6
|
4
|
4
|
33
|
35
|
10
|
15
|
11
|
288
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
16
|
6
|
3
|
3
|
1
|
0
|
2
|
8
|
6
|
3
|
6
|
4
|
4
|
33
|
35
|
10
|
15
|
11
|
288
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
8
|
13
|
8
|
3
|
6
|
0
|
0
|
32
|
25
|
140
|
30
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
10
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
10
|
10
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
5
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
17
|
6
|
3
|
4
|
1
|
5
|
4
|
12
|
14
|
18
|
16
|
8
|
11
|
34
|
36
|
43
|
51
|
163
|
323
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
5
|
7
|
8
|
7
|
32
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
5
|
7
|
8
|
7
|
32
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
5
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
17
N/A
|
6
-62%
|
4
-44%
|
4
+1%
|
1
-63%
|
5
+296%
|
6
+2%
|
14
+146%
|
16
+18%
|
19
+17%
|
16
-13%
|
9
-43%
|
11
+20%
|
35
+212%
|
41
+19%
|
50
+21%
|
59
+17%
|
170
+190%
|
356
+109%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
4
|
2
|
1
|
1
|
3
|
4
|
5
|
6
|
8
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
16
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
1
|
0
|
0
|
0
|
0
|
0
|
18
|
24
|
12
|
12
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
6
|
7
|
5
|
2
|
1
|
1
|
3
|
4
|
24
|
31
|
21
|
36
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
9
|
9
|
17
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
11
|
1
|
1
|
14
|
|
| Total Liabilities |
0
N/A
|
0
+50%
|
0
+33%
|
0
+75%
|
2
+1 250%
|
1
-30%
|
1
-52%
|
1
+67%
|
1
-50%
|
1
-2%
|
6
+1 045%
|
20
+228%
|
17
-14%
|
23
+33%
|
5
-78%
|
5
-8%
|
4
-8%
|
6
+50%
|
10
+55%
|
38
+285%
|
36
-6%
|
25
-31%
|
50
+100%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
13
|
26
|
34
|
40
|
45
|
7
|
16
|
22
|
35
|
54
|
52
|
67
|
74
|
88
|
108
|
137
|
159
|
200
|
305
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
28
|
31
|
37
|
42
|
46
|
12
|
16
|
16
|
34
|
50
|
63
|
71
|
81
|
116
|
139
|
149
|
182
|
344
|
610
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
0
N/A
|
0
-50%
|
0
-33%
|
0
-75%
|
15
N/A
|
5
-66%
|
3
-42%
|
3
-13%
|
1
-68%
|
5
+489%
|
1
N/A
|
6
-1 079%
|
1
+84%
|
4
-288%
|
11
N/A
|
5
-59%
|
7
+48%
|
28
+312%
|
31
+11%
|
12
-62%
|
23
+92%
|
145
+544%
|
306
+110%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
17
N/A
|
6
-62%
|
4
-44%
|
4
+1%
|
1
-63%
|
5
+296%
|
6
+2%
|
14
+146%
|
16
+18%
|
19
+17%
|
16
-13%
|
9
-43%
|
11
+20%
|
35
+212%
|
41
+19%
|
50
+21%
|
59
+17%
|
170
+190%
|
356
+109%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
5
|
21
|
24
|
25
|
31
|
46
|
57
|
|